May, 27 2019

STIMUNO as the only fitopharmaca immunomodulatory product in Indonesia, once again won the Top Brand for Kids award.

May, 23 2019

Consumer Health Dexa hold series of Ibu Herba Hebat Seminar with theme "Naturay Way to Optimal Growth and Development" at Bogor on May 21 2019.

May, 23 2019

Consumer Health Dexa conduct launching of "Ibu Herba Hebat" community at Ball Room Hotel Fave on May 15 2019.

May, 6 2019

Dexa Group with the Directorate General of Asia Pacific and Africa (Aspasaf) of the Ministry of Foreign Affairs of the Republic of Indonesia to hold promotive and preventive health promotion dissemination on Monday, April 29 2019 in Nusantara Space, Ministry of Foreign Affairs of the Republic of Indonesia.

May, 6 2019

Dexa Medica with the DKI Jakarta Ear, Nose and Throat Specialist Association for Head and Neck Surgery (Perhati-KL) hold a Symposium and Workshop on Update Management in Otorhinolaryngic Allergy.

May, 6 2019

Towards 50 years of National pharmaceutical innovation and research company serving in the health sector in Indonesia, Dexa Group collaborated with Kuark Magazine to hold the Kuark Science Olympiade (OSK).

March, 18 2019

Dexa Medica participated at National Work Meeting and Annual Scientific Meeting of Indonesian Pharmacists Association. (IAI

February, 13 2019

Dexa Group's products of research and innovation attended on Medical Devices and Pharmaceutical Products Exhibition at the 2019 National Health Work Meeting.
 

February, 13 2019

Dexa Group proves its consistency for contributes on health sector by gathering Dynamic Argon, Co., Ltd. in Cambodia.

February, 13 2019

CEO Dexa Group, Mr. Ferry A. Soetikno, got an awarded  Indonesia Most Admired CEO 2018 for  Excellent Leadership for Supporting Government Health Programs category.

February, 13 2019

Dexa Medica received Innovative Industrial Research and Development Institution (IIRDI) Award 2018 from Ministry of Research, Technology and Higher Education.

November, 28 2018

Dexa Medica participated The First Meeting of Heads of National Medicines Regulatory Authorities (NMRAs) from OIC.

Pages